drugset / Trial / NCT03934216
Safety and Efficacy of Deucravacitinib in Participants With Moderate to Severe Ulcerative Colitis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to assess the safety and efficacy of oral deucravacitinib in participants with moderate to severe ulcerative colitis (UC).
Timeline
- Start
- 2019-07-01
- Primary completion
- 2021-06-13
- Completion
- 2023-04-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CRAVACITINIB | Small molecule | — | Oral |